参考文献/References:
[1] Smith GP. Filamentous fusion phage:novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228(4705):1315-1317.
[2] Bazan J, Calkosinski I, Gamian A. Phage display-a powerful technique for immunotherapy:1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother, 2012, 8(12):1817-1828.
[3] Castel G, Chtéoui M, Heyd B, et al. Phage display of combinatorial peptide libraries:application to antiviral research. Molecules, 2011,16(5):3499-3518.
[4] Jurisson SS, Lydon JD. Potential technetium small molecule radiopharmaceuticals. Chem Rev, 1999, 99(9):2205-2207.
[5] Bourguignon MH, Loc’h G, Mazifere B. The future of SPECT radioisotopes:technetium-99m or iodine-123?. J Nucl Biol Med, 1994,38(4):573-576.
[6] Cutler SJ, Perez KL, Beimhart HX, et al. Observer detection limits for a dedicated SPECT breast imaging system. Phys Med Biol, 2010,55(7):1903-1916.
[7] Chen L, Wang Y, Cheng D, et al. Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents. Nucl Med Commun, 2011, 32(10):920-924.
[8] Rusckowski M, Gupta S, Liu G, et al. Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen. Cancer Biother Radiopharm, 2007, 22(4):564-572.
[9] Hui X, Han Y, Liang S, et al. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC. J Control Release, 2008, 131(2):86-93.
[10] 兰晓莉,高再荣,孙琳,等.核素标记血管多肽显像诊断恶性肿瘤实验研究.肿瘤学杂志,2008,14(8):627-630.
[11] Bakker WH, Krenning EP, Reubi JC, et al. In vivo application of luIn-DTPA-D-Phel]-octreotide for detection of somatostatin receptorpositive tumors in rats. Life Sci, 1991,49(22):1593-1601.
[12] Anderson CJ, Welch MJ. Radiometal-labeled agents (nontechnetium) for diagnostic imaging. Chem Rev, 1999, 99(9):2219-2234.
[13] Boswell CA, Mundo EE, Zhang C, et al. Differential effects of predosing on tumor and tissue uptake of an inIn-labeled anti-TENB2 antibody-drug conjugate. J Nucl Med, 2012, 53(9):1454-1461.
[14] Zou J, Glinsky VV, Landon LA, et al. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis, 2005, 26(2):309-318.
[15] Kumar SR, Deutscher SL. IIIIn-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors. J Nucl Med, 2008, 49(5):796-803.
[16] Hooker SD, Freeman LH, Stewart P. Pet therapy research:a historical review. Holist Nurs Pract, 2002, 16(5):17-23.
[17] Champion L, Brain E, Giraudet AL, et al. Breast cancer recurrence diagnosis suspected on tumor marker rising:value of whole-body 18FDG-PET/CT imaging and impact on patient management. Cancer,2011, 117(8):1621-1629.
[18] Picchio M, Giovannini E, Crivellaro C, et al. Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. Radiother Oncol, 2010,96(3):347-350.
[19] SUN L, CHU T, WANG Y, et al. Radiolabeling and biodistribution of a nasopharyngeal carcinoma-targeting peptide identified by in vivo phage display. Acta Biochim Biophys Sin (Shanghai), 2007, 39(8):624-632.
[20] Zitzmann S, Mier W, Schad A, et al. A new prostate carcinoma binding peptide(DUP-1)for tumor imaging and therapy. Clin Cancer Res, 2005, 11(1):139-146.
[21] Anthony LB, Woltering EA, Espenan GD, et al. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies. Semin Nucl Med, 2002, 32(2):123-132.
[22] Mitra A, Nan A, Papadimitriou JC, et al. Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nucl Med Biol, 2006,33(1):43-52.
[23] Reubi C, Gugger M, Waser B. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging, 2002, 29(7):855-862.
[24] Paganelli G, Bodei L, Handkiewicz Junak D, et al. 90Y-DOTA-D-Phel-Try3-octreotide in therapy of neuroendocrine malignancies. Biopolymers, 2002,66(6):393-398.
[25] Zitzmann S,Kiiimer S,Mier W, et al. Identification and evaluation of a new tumor cell-binding peptide, FROP-1. J Nucl Med, 2007, 48(6):965-972.
相似文献/References:
[1]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[5]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[6]周惠君,董萍,沈国华,等.11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J].国际放射医学核医学杂志,2015,39(2):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
Zhou Huijun,Dong Ping,Shen Guohua,et al.Value of 11C-methionine PET/CT imaging indiagnosing cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
[7]张华,姚振威.细胞示踪影像学技术的发展[J].国际放射医学核医学杂志,2015,39(2):180.[doi:10.3760/cma.j.issn.1673-4114.2015.02.017]
Zhang Hua,Yao Zhenwei.The development of cell tracking technology[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):180.[doi:10.3760/cma.j.issn.1673-4114.2015.02.017]
[8]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[9]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[10]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]